Results
20,303 records
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 18 | Reierson Amanda LDirector |  PRCHPorch Group, Inc.Open-market sale · 10b5-1 plan | SELL | $153K 8,501 sh | Oct 7, 2026 traded Oct 6, 2026 | |
Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 18 | Reierson Amanda LDirector | PRCHPorch Group, Inc. Open-market sale · 10b5-1 plan | SELL | $153K 8,501 sh | Oct 7, 2026 traded Oct 6, 2026 | |
Herb TylerChief Accounting Officer |
 FIGFigma, Inc.Open-market sale · 10b5-1 plan |
| SELL |
| $31K 1,418 sh |
| Oct 7, 2026 traded Oct 5, 2026 |
| 17 | Maetzold Derek JDirector, Pres. & Chief Exec. Officer |  CSTLCASTLE BIOSCIENCES INCOpen-market sale · 10b5-1 plan | SELL | $305K 8,580 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 17 |  Neri Antonio FDirector, President and CEO |  HPEHewlett Packard Enterprise CoOpen-market sale · 10b5-1 plan | SELL | $13.20M 193.3K sh | Oct 7, 2026 traded Oct 5, 2026 |
| 17 | Cooper Matthew WGeneral Counsel & Corp Secy |  COFCAPITAL ONE FINANCIAL CORPOpen-market sale · 10b5-1 plan | SELL | $687K 3,500 sh | Oct 7, 2026 traded Oct 6, 2026 |
| 16 | Cheng Chi FungDirector, Chief Technology Officer |  CRDOCredo Technology Group Holding LtdOpen-market sale · 10b5-1 plan | SELL | $64K 300 sh | Oct 7, 2026 traded Oct 6, 2026 |
| 16 |  Maria Elvira SalazarRSelf |  BIIBBIOGEN INC.Partial sale | SELL | $1,001 – $15K | Oct 7, 2026 traded Sep 24, 2026 |
| 16 | Gallagher Daniel Martin JrChief Legal Officer |  HOODRobinhood Markets, Inc.Open-market sale · 10b5-1 plan | SELL | $58K 500 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 16 | Xu ZhenyuChief Scientific Officer |  SOPHSOPHiA GENETICS SAOpen-market sale · 10b5-1 plan | SELL | $60K 7,394 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 16 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $64K 300 sh | Oct 7, 2026 traded Oct 6, 2026 |
| 16 | Maria Elvira SalazarRSelf |  MRNAModerna, Inc.Partial sale | SELL | $1,001 – $15K | Oct 7, 2026 traded Sep 24, 2026 |
| 16 | Muken RossDirector, Chief Executive Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $80K 9,838 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 16 | Collier CharlesPresident, Roku Media |  ROKUROKU, INCOpen-market sale · 10b5-1 plan | SELL | $88K 580 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 16 | Menu PhilippeChief Medical Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $60K 7,394 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 16 | Van Well DaanChief Legal Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $50K 6,168 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 16 | Collier CharlesPresident, Roku Media | ROKUROKU, INC Open-market sale · 10b5-1 plan | SELL | $64K 424 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 16 | Holleran KevinDirector, President and CEO |  HAYWHayward Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $620K 50.0K sh | Oct 7, 2026 traded Oct 5, 2026 |
| 16 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $225K 1,000 sh | Oct 7, 2026 traded Oct 6, 2026 |
| 16 | Enguent Jean-PierreVice President, R&DSS |  LAESSEALSQ CorpOpen-market sale · 10b5-1 plan | SELL | $86K 35.0K sh | Oct 7, 2026 traded Oct 6, 2026 |
| 16 | Allaire JeremyDirector, Chairman and CEO |  CRCLCircle Internet Group, Inc.Open-market sale · 10b5-1 plan | SELL | $2.77M 33.1K sh | Oct 7, 2026 traded Oct 5, 2026 |
| 15 |  Sahin UgurChief Executive Officer, 10% Owner |  BNTXBioNTech SEOpen-market sale · 10b5-1 plan | SELL | $2.30M 24.0K sh | Oct 7, 2026 traded Oct 7, 2026 |
| 15 | Tsao DavidDirector, Chief Technology Officer |  BLLNBillionToOne, Inc.Open-market sale · 10b5-1 plan | SELL | $59K 555 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 15 | ten Bosch John RoderickSVP of Laboratory Operations | BLLNBillionToOne, Inc. Open-market sale · 10b5-1 plan | SELL | $149K 1,417 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 15 | Tsao DavidDirector, Chief Technology Officer | BLLNBillionToOne, Inc. Open-market sale · 10b5-1 plan | SELL | $205K 1,909 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 15 | ten Bosch John RoderickSVP of Laboratory Operations | BLLNBillionToOne, Inc. Open-market sale · 10b5-1 plan | SELL | $149K 1,417 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 15 | Gruber JulieChief Legal&Compliance Officer |  GAPGAP INCOpen-market sale · 10b5-1 plan | SELL | $649K 27.5K sh | Oct 7, 2026 traded Oct 6, 2026 |
| 15 | Parisotto Shannon MCEVP, Disc & Safety Assessment |  CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.Open-market sale · 10b5-1 plan | SELL | $303K 981 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 14 | Ong Chin YinChief Org Capability Officer |  GRABGrab Holdings LtdOpen-market sale · 10b5-1 plan | SELL | $117K 38.0K sh | Oct 7, 2026 traded Oct 5, 2026 |
| 14 | Enslin RobertPresident, CCO |  WDAYWorkday, Inc.Open-market sale · 10b5-1 plan | SELL | $317K 1,700 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 14 | Maetzold Derek JDirector, Pres. & Chief Exec. Officer | CSTLCASTLE BIOSCIENCES INC Open-market sale · 10b5-1 plan | SELL | $97K 2,718 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 14 | Maetzold Derek JDirector, Pres. & Chief Exec. Officer | CSTLCASTLE BIOSCIENCES INC Open-market sale · 10b5-1 plan | SELL | $114K 3,198 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 14 | Duffy Matthew PaulPresident & Chief Risk Officer, Positions held at subsidiary |  NPNeptune Insurance Holdings Inc.Open-market sale · 10b5-1 plan | SELL | $1.12M 41.4K sh | Oct 7, 2026 traded Oct 6, 2026 |
| 14 | Enslin RobertPresident, CCO | WDAYWorkday, Inc. Open-market sale · 10b5-1 plan | SELL | $392K 2,091 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 13 | Holme TimothyCHIEF TECHNOLOGY OFFICER |  QSQuantumScape CorpOpen-market sale · 10b5-1 plan | SELL | $102K 22.5K sh | Oct 7, 2026 traded Oct 5, 2026 |
| 13 | Cardoza GeorgeChief Financial Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $13K 1,592 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 13 | Verma AbhimanyuChief Technology Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $43K 5,284 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 13 | Holme TimothyCHIEF TECHNOLOGY OFFICER | QSQuantumScape Corp Open-market sale · 10b5-1 plan | SELL | $102K 22.5K sh | Oct 7, 2026 traded Oct 5, 2026 |
| 13 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $42K 200 sh | Oct 7, 2026 traded Oct 6, 2026 |
| 13 | Reynoso Jamie L.CEO, Medicare Advantage |  CLOVCLOVER HEALTH INVESTMENTS, CORP. /DEOpen-market sale · 10b5-1 plan | SELL | $9,288 2,006 sh | Oct 7, 2026 traded Oct 7, 2026 |
| 13 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $44K 200 sh | Oct 7, 2026 traded Oct 6, 2026 |